IMPALA PLATINUM/S (OTCMKTS:IMPUY) Share Price Passes Below Fifty Day Moving Average of $8.34

Share on StockTwits

IMPALA PLATINUM/S (OTCMKTS:IMPUY) shares passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $8.34 and traded as low as $3.00. IMPALA PLATINUM/S shares last traded at $3.00, with a volume of 111,056 shares.

A number of brokerages have recently issued reports on IMPUY. ValuEngine upgraded shares of IMPALA PLATINUM/S from a “sell” rating to a “hold” rating in a research report on Wednesday, March 18th. Zacks Investment Research upgraded shares of IMPALA PLATINUM/S from a “hold” rating to a “strong-buy” rating and set a $11.00 target price on the stock in a research report on Thursday, January 30th.

The company has a debt-to-equity ratio of 0.16, a current ratio of 2.36 and a quick ratio of 1.21. The firm has a market capitalization of $2.84 billion, a PE ratio of 16.62, a price-to-earnings-growth ratio of 0.10 and a beta of 1.36. The business’s 50-day moving average price is $8.22 and its 200-day moving average price is $8.10.

The firm also recently announced a Semi-Annual dividend, which will be paid on Monday, March 30th. Stockholders of record on Friday, March 20th will be given a dividend of $0.065 per share. The ex-dividend date of this dividend is Thursday, March 19th. IMPALA PLATINUM/S’s dividend payout ratio (DPR) is presently 44.83%.

IMPALA PLATINUM/S Company Profile (OTCMKTS:IMPUY)

Impala Platinum Holdings Limited engages in mining, processing, refining, and marketing platinum and associated platinum group metals (PGMs) in South Africa and Zimbabwe. It operates through Mining Operations, Refining Services, Chrome Processing, and Other segments. The company produces platinum, palladium, and rhodium, as well as nickel.

Recommended Story: Does the Step Transaction Doctrine Affect a Backdoor Roth IRA?

Receive News & Ratings for IMPALA PLATINUM/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMPALA PLATINUM/S and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.